Lourdes Riquelme, Author at Labiotech.eu

About

Spanish Biotechnologist with a MS in Genetics from Universidad Autonoma of Barcelona. My interests go from science to fashion and anything in between.

Articles by Lourdes Riquelme

News and Trends 1 Jun 2015

CRISPR technology receives the Spanish ‘Nobel prize’

CRISPR continues to amass prizes and to consolidate itself as the biggest discovery of the century. Its discoverers received last Wednesday the Princess of Asturias Award of Technical and Scientific Research. Emmanuel Charpentier and Jennifer Doudna, who shared the prize, received €50k. The prize was established in 1980 and consists in a series of annual prizes […]

June 1, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 27 May 2015

Qiagen offers a powerful bioinformatics tool for Next-gen sequencing

Qiagen has launched its Qiagen Clinical Insight bioinformatics content and software platform. The software aims at clinical testing labs that perform next generation sequencing. The platform allows interpreting and reporting on genomic variants identified in the sequencing assays. The Clinical Insight platform is a potent tool that evaluates genomic variants comparing them with published biomedical […]

May 27, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 27 May 2015

NewCo, the union of Sorin and Cyberonics

[UPDATE 27/05/2015]: Sorin’ shareholders approved the merger with Cyberonics in an Extraordinary Meeting. Sorin and Cyberonics, agreed on a merger plan to create a new global leader in medical technologies with a combined equity value of approximately €2.4Bn based on the closing price of Sorin and Cyberonics shares of 25th February. Sorin and Cyberonics will combine […]

May 27, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 27 May 2015

Amgen dumps suicidal-related AstraZeneca’s psoriasis project

AstraZeneca might be facing a public crisis after its partner, Amgen, decided to abandon their common project on psoriasis. The Americans made a getaway from the collaboration after patients treated with brodalumab not only reported to have suicidal ideation, but even committed suicide… AstraZeneca and Amgen’s partnership started back in 2012, as both companies resolved to jointly […]

May 27, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 May 2015

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

Antibiotics abuse is creating a whole new generation of antibiotic-resistant bacteria. As the tolerance to antibiotics grows, the battle against bacteria is getting harder and becoming a public issue. However, Humans are not the only ones trying to fight bacteria. Some viruses, the phages, have been doing it for millenniums. Udi Qimron and his team […]

May 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 25 May 2015

The most influential people in European biopharma

Fierce Biotech has released its long-awaited list of the 25 most influential people in the biopharma field. The inventory has a good European presence with professionals that are revolutionizing the industry. Hans Bishop, from Juno Therapeutics. The CEO of the American rising star in the biotech industry was born and raised in UK. The company, he […]

May 25, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 24 May 2015

Pluristem accelerates its Cell Therapy program thanks to the EMA

Pluristem Therapeutics has good reasons to celebrate: its PLX cell program in critical limb ischemia is taking the fast line to the market. The program is the first to have been selected for the European Medicines Agency’s Adaptive Pathways pilot project, which aims at accelerating the access for patients to new medicines. The purpose of Europe’s Adaptive Pathways is […]

May 24, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 May 2015

arGEN-X’ Antibody Platform struck a new Dermatology alliance

arGEN-X and LEO Pharma allied to develop innovative antibody-based solutions for the treatment of chronic inflammation underlying many skin conditions. The deal amounts to a total of €104.5M, from which arGEN-X will receive €4.5M as an upfront payment and up to €100M in royalties. LEO Pharma will receive exclusive access to an already existing arGEN-X antibody […]

May 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 May 2015

Fluorescent antibodies to guide Cancer surgery

French oncologist SurgiMab has started a first-in-human phase I study for its molecule SGM-101 launched at the Montpellier Cancer Institute. SurgiMab is developing antibody-fluorochrome conjugates to be used as in vivo diagnostic agents in oncology. SGM-101 is a fluorescent conjugate that consists on a tumor-specific monoclonal antibody and a near-infrared emitting fluorochrome. Thanks to this conjugate, oncology surgeons will […]

May 22, 2015 - 1 minutemin - By Lourdes Riquelme

IBN One Cristal union Global bioenergies

News and Trends 21 May 2015

Will France become a leader in isobutene production?

Cristal Union and Global Bioenergies have formed a joint venture, entitles IBN-One, to build and operate France’s first bio-sourced isobutene production plant. IBN-One is a limited liability corporation jointly owned by the two companies. The two French companies already collaborated to develop the scaling up of the isobutene production process. Thanks to the partnership, the […]

May 21, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 21 May 2015

The most effective Test for Ovarian Cancer raised €7.4M

Cancer is a devastating disease and, despite all the best efforts to develop new personalized medicines, too many lives end every year because of it. However, this trend might be about to change, after the latest study from University College London, published in the Journal of Clinical Oncology last week. The study highlighted that ROCA, […]

May 21, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 20 May 2015

[UPDATE] Galapagos with €277.3M, made the Biggest European Biotech IPO ever on NASDAQ

[UPDATE 20/05/2015]: Galapagos announced the closing of its NASDAQ IPO, where the company raised a total of €277.3M. Galapagos has once again made the front page thanks to its unbeaten IPO. The company just raised €240M on Nasdaq, becoming the biggest European biotech IPO ever on the US stock market. The Belgium company just ranked […]

May 20, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Lourdes Riquelme

About

Articles by Lourdes Riquelme

CRISPR technology receives the Spanish ‘Nobel prize’

Qiagen offers a powerful bioinformatics tool for Next-gen sequencing

NewCo, the union of Sorin and Cyberonics

Amgen dumps suicidal-related AstraZeneca’s psoriasis project

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

The most influential people in European biopharma

Pluristem accelerates its Cell Therapy program thanks to the EMA

arGEN-X’ Antibody Platform struck a new Dermatology alliance

Fluorescent antibodies to guide Cancer surgery

Will France become a leader in isobutene production?

The most effective Test for Ovarian Cancer raised €7.4M

[UPDATE] Galapagos with €277.3M, made the Biggest European Biotech IPO ever on NASDAQ

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Lourdes Riquelme

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!